Cost-effectiveness of evolocumab therapy for reducing cardiovascular events in patients with atherosclerotic cardiovascular disease

1. Fonarow, G.C.
2. Keech, A.C.
3. Pedersen, T.R.
4. Giugliano, R.P.
5. Sever, P.S.
6. Lindgren, P.
7. Van Hout, B.
8. Villa, G.
9. Qian, Y.
10. Somaratne, R.
11. Sabatine, M.S.